XM levert geen diensten aan inwoners van de Verenigde Staten.

XM levert geen diensten aan inwoners van de Verenigde Staten.
I
I

IQVIA

Nieuws

Reuters - 4 dagen geleden

Medpace tumbles after bookings disappoint

BUZZ-Medpace tumbles after bookings disappoint ** Medpace's MEDP.O shares down 13.6% premarket to three-mth low $377.91 after clinical contract research organization's bookings miss expectations ** Co late Mon reported Q2 new business awards decreased 4% yr/yr for net book-to-bill ratio (number of orders received to those fulfilled) of 1.04x ** TD Cowen, which rates MEDP "buy", pointed out that consensus called for book-to-bill ratio of 1.23x ** While unclear what drove bookings weakness, some e
I
Reuters - 4 dagen geleden

U.S. Colgate-Palmolive, McKesson, Microsoft

U.S. RESEARCH ROUNDUP-Colgate-Palmolive, McKesson, Microsoft July 23 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Colgate-Palmolive, McKesson and Microsoft, on Tuesday. HIGHLIGHTS * Colgate-Palmolive Co CL.N : TD Cowen initiates coverage with buy rating; PT $110 * DR Horton Inc DHI.N : JP Morgan raises target price to $180 from $163 * IQVIA Holdings Inc IQV.N : Baird raises target price to $251 from $235 * McKesso
C
H
M
M
T
V
Z
F
A
M
A
C
C
D
I
Reuters - 4 dagen geleden

S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT

BUZZ - S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT S&P 500 .SPX Top Performers Percent Change IQVIA Holdings Inc IQV.N +7.7% Lam Research Corp LRCX.OQ +6% ON Semiconductor Corp ON.OQ +5.9% Applied Materials Inc AMAT.OQ +5.8% KLA Corp KLAC.OQ +5.5% Bottom Performers Percent Change CrowdStrike Holdings Inc CRWD.OQ -13.2% Verizon
S
V
K
L
O
U
A
C
I
Reuters - 4 dagen geleden

U.S. STOCKS Walt Disney, Mattel, Tellurian

BUZZ-U.S. STOCKS ON THE MOVE-Walt Disney, Mattel, Tellurian Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 The S&P 500 and the Nasdaq recouped some of the previous week's losses on Monday, as investors reexamined the chances of a second presidential term for Republican nominee Donald Trump after U.S.
G
M
N
S
S
V
A
C
L
U
U
A
G
I
N
Reuters - 4 dagen geleden

S&P 500 top and bottom performing stocks at about 12:00 p.m. EDT

BUZZ - S&P 500 top and bottom performing stocks at about 12:00 p.m. EDT S&P 500 .SPX Top Performers Percent Change IQVIA Holdings Inc IQV.N +6.6% ON Semiconductor Corp ON.OQ +4.7% Lam Research Corp LRCX.OQ +4.2% Applied Materials Inc AMAT.OQ +3.9% KLA Corp KLAC.OQ +3.9% Bottom Performers Percent Change CrowdStrike Holdings Inc CRWD.OQ -13.0% Verizo
S
V
K
L
O
U
A
C
I
Reuters - 4 dagen geleden

U.S. STOCKS Verizon Communications, Reddit, Starbucks

BUZZ-U.S. STOCKS ON THE MOVE-Verizon Communications, Reddit, Starbucks Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street rose on Monday, regaining some ground after the previous week's declines as investors assessed the odds of a second term for Republican nominee Donald Trump in the November election after President Joe Biden withdrew from the race.
G
N
S
S
V
A
C
L
O
U
U
G
I
Reuters - 5 dagen geleden

IQVIA climbs on annual profit forecast raise

BUZZ-IQVIA climbs on annual profit forecast raise ** Shares of contract research firm IQVIA Holdings IQV.N rise ~6.7% to $239.60, highest since April ** Co forecasts annual adj. profit between $11.10 and $11.30 per share, above its prior range of $10.95 to $11.25 ** Co reports Q2 adj. profit of $2.64/shr vs analysts' average estimate of $2.57/shr -
I
Reuters - 5 dagen geleden

IQVIA Holdings Inc reports results for the quarter ended in January - Earnings Summary

IQVIA Holdings Inc reports results for the quarter ended in January - Earnings Summary IQVIA Holdings Inc IQV.N reported quarterly adjusted earnings of $2.64​​ per share for the quarter ended in January, higher than the same quarter last year, when the company reported EPS of $2.43. The mean expectation of twenty one analysts for the quarter was for earnings of $2.57 per share.
I
Reuters - 5 dagen geleden

IQVIA raises annual profit forecast on improving demand for analytics services

IQVIA raises annual profit forecast on improving demand for analytics services July 22 (Reuters) - Contract research firm IQVIA Holdings IQV.N raised its forecast for full-year profit on Monday, banking on strength in demand for its healthcare data and analytics services. Technological and analytical solutions (TAS), IQVIA's second-largest unit, reported a 2.7% rise in second-quarter revenue to $1.50 billion, above estimates of $1.47 billion, according to LSEG data.
I
Reuters - 5 dagen geleden

IQVIA Q2 Adjusted EPS USD 2.64 Vs. IBES Estimate USD 2.57

BRIEF-IQVIA Q2 Adjusted EPS USD 2.64 Vs. IBES Estimate USD 2.57 Jul 22 (Reuters) - IQVIA Q2 net income USD 363 million. Q2 revenue USD 3,814 million vs. IBES estimate USD 3,789 million Q2 adjusted EBITDA USD 887 million vs. IBES estimate USD 884 million Q2 EPS USD 1.97
I
Reuters - 5 dagen geleden

Biden bows out, election bets shift, China cuts

MORNING BID AMERICAS-Biden bows out, election bets shift, China cuts A look at the day ahead in U.S. and global markets from Mike Dolan U.S. President Joe Biden's weekend withdrawal from the White House race can hardly be seen as a big surprise, but it adds some doubts to market bets that Republican challenger Donald Trump is a shoo-in in November's election.
B
C
D
G
G
L
N
N
T
U
U
V
G
J
U
U
U
F
W
I
Reuters - 1 week geleden

IQVIA Holdings Inc <IQV.N> expected to post earnings of $2.57 a share - Earnings Preview

IQVIA Holdings Inc expected to post earnings of $2.57 a share - Earnings Preview IQVIA Holdings Inc IQV.N , IQV is expected to show a rise in quarterly revenue when it reports results on July 22 for the period ending June 30 2024 The Durham North Carolina-based company is expected to report a 1.6% increase in revenue to $3.789 billion from $3.73 billion a year ago, according to the mean estimate from 18 analysts, based on LSEG data.The company's guidance on May 2 2024, for the period ended June
I
Reuters - 1 week geleden

Novo Nordisk obesity feast no longer a free lunch

BREAKINGVIEWS-Novo Nordisk obesity feast no longer a free lunch The author is a Reuters Breakingviews columnist. The opinions expressed are her own. By Aimee Donnellan LONDON, July 18 (Reuters Breakingviews) - Novo Nordisk NOVOb.CO is going to have to work hard to justify its bulging valuation. The $603 billion obesity drug maker’s shares have more than trebled since 2021 thanks to insatiable appetite for its weight-loss drug.
A
P
R
I
Reuters - 1 maand geleden

U.S. Avidity Biosciences, Broadcom, Cara Therapeutics

U.S. RESEARCH ROUNDUP-Avidity Biosciences, Broadcom, Cara Therapeutics June 13 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Avidity Biosciences, Broadcom and Cara Therapeutics, on Thursday. HIGHLIGHTS * Avidity Biosciences Inc RNA.O : Leerink Partners raises target price to $56 from $38 * Broadcom Inc AVGO.O : TD Cowen raises target price to $1,750 from $1,500 * Cara Therapeutics Inc CARA.O : Canaccord Genuity cut
B
B
C
C
G
M
C
A
D
I
L
Reuters - 2 maanden geleden

Iqvia Launches “One Home” Clinical Trial Technology Platform – Solves Challenges And Reduces Overload At Sites

BRIEF-Iqvia Launches “One Home” Clinical Trial Technology Platform – Solves Challenges And Reduces Overload At Sites June 12 (Reuters) - IQVIA Holdings Inc IQV.N : IQVIA LAUNCHES “ONE HOME” CLINICAL TRIAL TECHNOLOGY PLATFORM – SOLVES CHALLENGES AND REDUCES OVERLOAD AT SITES Source text for Eikon: ID:nBw7w4l7Ta Further company coverage:
I
Reuters - 2 maanden geleden

UK's Hikma gains as Citi raises target price

BUZZ-UK's Hikma gains as Citi raises target price ** Shares of British drugmaker Hikma Pharmaceuticals HIK.L up 3% at 1,989p ** Stock is top pct gainer on FTSE 100 index .FTSE ** Brokerage Citigroup raises target price to 2845p from 2770p ** Research firm IQVIA's data on HIK highly encouraging; we go to the top-end of forecast range - Citi ** Hikma
H
U
I
Reuters - 3 maanden geleden

IQVIA trims full-year revenue forecast on stronger dollar

IQVIA trims full-year revenue forecast on stronger dollar May 2 (Reuters) - Contract research firm IQVIA Holdings IQV.N lowered its annual revenue forecast on Thursday due to a stronger dollar and reported a quarter-over-quarter fall in a closely-watched metric, sending shares down nearly 4%. The company expects 2024 revenue of $15.33 billion to $15.58 billion, versus its previous forecast of between $15.4 billion and $15.65 billion, as a strengthening dollar hit sales in its large international
I
Reuters - 3 maanden geleden

IQVIA Holdings Inc reports results for the quarter ended in March - Earnings Summary

IQVIA Holdings Inc reports results for the quarter ended in March - Earnings Summary IQVIA Holdings Inc IQV.N reported quarterly adjusted earnings of $2.54​​ per share for the quarter ended in March, higher than the same quarter last year, when the company reported EPS of $2.45. The mean expectation of twenty analysts for the quarter was for earnings of $2.48 per share.
I
Reuters - 3 maanden geleden

IQVIA Q1 Adjusted EPS USD 2.54 Vs. IBES Estimate USD 2.48

BRIEF-IQVIA Q1 Adjusted EPS USD 2.54 Vs. IBES Estimate USD 2.48 May 02 (Reuters) - IQVIA Q1 revenue USD 3,737 million vs. IBES estimate USD 3,699 million. Q1 net income USD 288 million Q1 adjusted EBITDA USD 862 million vs. IBES estimate USD 862.7 million Q1 EPS USD 1.56
I
Reuters - 3 maanden geleden

Fed QT taper calms the horses, yen pops again

MORNING BID AMERICAS-Fed QT taper calms the horses, yen pops again A look at the day ahead in U.S. and global markets from Mike Dolan Anxious bond traders seem to have taken solace from the Federal Reserve's surprisingly sharp brake on its "quantitative tightening" process on Wednesday, while the yen capitalized on an easier dollar after what seemed like the second bout of Japanese intervention this week.
A
A
A
C
E
H
I
R
S
U
A
U
I
V
W
Z
A
B
D
H
I
L
P
P
P
T

Voorwaarden

Populaire activa

Disclaimer: De entiteiten van de XM Group bieden diensten en toegang tot ons online handelsplatform op basis van uitsluitend-uitvoering, waardoor een persoon de beschikbare content op of via de website kan bekijken en/of gebruiken, zonder dat dit is bedoeld voor wijziging of uitbreiding. Dergelijk(e) toegang en gebruik vallen onder: (i) de algemene voorwaarden; (ii) risicowaarschuwingen; en de (iii) volledige disclaimer. Dergelijke content wordt daarom alleen aangeboden als algemene informatie. Wees u er daarnaast vooral van bewust dat de inhoud op ons online handelsplatform geen verzoek of aanbieding omvat om transacties op de financiële markten uit te voeren. Het beleggen op welke financiële markt dan ook vormt een aanzienlijk risico voor uw vermogen.

Alle materialen die op ons online handelsplatform worden gepubliceerd zijn bedoeld voor educatieve/informatieve doeleinden en omvatten geen – en moeten niet worden beschouwd als het bevatten van – financieel, vermogensbelastings- of handelsadvies en aanbevelingen, of een overzicht van onze handelsprijzen, of een aanbod of aanvraag van een transactie in financiële instrumenten of ongevraagde financiële promoties voor u.

Alle content van derden, alsmede content die is voorbereid door XM, zoals opinies, nieuws, onderzoeken, analyses, prijzen en andere informatie of koppelingen naar externe websites op deze website worden aangeboden op een 'zoals-ze-zijn'-basis, als algemene marktcommentaren, en vormen geen beleggingsadvies. Voor zover dat content wordt beschouwd als beleggingsonderzoek, moet u zich ervan bewust zijn en accepteren dat de content niet bedoeld was en niet is voorbereid in overeenstemming met de wettelijke vereisten die zijn opgesteld om de onafhankelijkheid van beleggingsonderzoek te bevorderen en als zodanig onder de geldende wetgeving en richtlijnen moet worden beschouwd als marketingcommunicatie. Zorg ervoor dat u onze Mededeling over niet-onafhankelijk beleggingsonderzoek en risicowaarschuwing in verband met de voorgaande informatie doorneemt en begrijpt; die kunt u hier lezen.

Risicowaarschuwing: Uw vermogen loopt risico. Hefboomproducten zijn mogelijk niet voor iedereen geschikt. Lees onze informatie over risico's.